Faculty

Mark J. Truty, M.D., M.S.

Clinical Studies

Aggressive Malignancy PDX (Avatar) and Cryopreservation Program (PDX) Rochester, Minn.
The purpose of this study is to assess the ability to successfully create numerous validated patient-derived xenograft (PDX) models from patient tumor specimens obtained at surgery/biopsy via the new Pathology/TRAG cryopreservation protocol, and to generate a large catalog and repertoire of previously unavailable histologically validated PDX.

Exploring The Potential Of Duodenal Microbial And Metabolic Diversity As A Biomarker Of Pancreatic Cancer Rochester, Minn.
To determine whether the microbiome, metagenome and metabolome of the tissue of the second portion of duodenum of patients with pancreatic cancer are different from that of patients with benign conditions not affecting the pancreas.